Ignite Creation Date:
2024-05-06 @ 5:49 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05442190
Status:
RECRUITING
Last Update Posted:
2024-04-24
First Post:
2022-06-28
Brief Title:
Topical SGX302 for Mild-to-Moderate Psoriasis
Sponsor:
Soligenix
Organization:
Soligenix
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-28
First Submit QC Date:
June 28 2022
Study First Post Date:
2022-07-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-23
Last Update Post Date:
2024-04-24
Last Update Post Date Type:
ACTUAL